Your browser doesn't support javascript.
loading
Fall in thyroid stimulating hormone (TSH) may be an early marker of ipilimumab-induced hypophysitis.
De Sousa, Sunita M C; Sheriff, Nisa; Tran, Chau H; Menzies, Alexander M; Tsang, Venessa H M; Long, Georgina V; Tonks, Katherine T T.
Afiliação
  • De Sousa SMC; Endocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide, Australia.
  • Sheriff N; Department of Genetics and Molecular Pathology, Centre for Cancer Biology, an SA Pathology and University of South Australia Alliance, Adelaide, Australia.
  • Tran CH; School of Medicine, University of Adelaide, Adelaide, Australia.
  • Menzies AM; Department of Endocrinology, St Vincent's Hospital, Darlinghurst, Australia.
  • Tsang VHM; Diabetes and Metabolism Program, Garvan Institute of Medical Research, Darlinghurst, Australia.
  • Long GV; Department of Endocrinology, St Vincent's Hospital, Darlinghurst, Australia.
  • Tonks KTT; St Vincent's Clinical School, University of New South Wales, Sydney, Australia.
Pituitary ; 21(3): 274-282, 2018 Jun.
Article em En | MEDLINE | ID: mdl-29380110
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tireotropina / Hipofisite / Ipilimumab Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tireotropina / Hipofisite / Ipilimumab Idioma: En Ano de publicação: 2018 Tipo de documento: Article